Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMB
- Status
- COMPLETED
- Phase
- NA
Effects of Exercise in Patients With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot Intervention
- Status
- TERMINATED
- Phase
- NA
Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE4
Implementing Patients´ Competence in Oral Breast Cancer Therapy
- Status
- UNKNOWN
- Phase
- N/A
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of TAS-120 in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- Status
- RECRUITING
- Phase
- PHASE1